What is the NOAEL for 3-Benzylidenebornan-2-one?
3-Benzylidenebornan-2-one has 68 NOAEL studies in the database. The lowest reported value is 0.21 mg/kg bw via oral in rat. Source: UnifiedCodex:SCCS_SHADOW:beta.noael_studies.
Also known as: Bicyclo[2.2.1]heptan-2-one, 1,7,7-trimethyl-3-(phenylmethylene)-, 2-Bornanone, 3-benzylidene-, 1,7,7-Trimethyl-3-(phenylmethylene)bicyclo[2.2.1]heptan-2-one, 3-Benzylidenecamphor, Benzylidenecamphor (+8 more)
CAS 15087-24-8
3-Benzylidenebornan-2-one (CAS 15087-24-8) is a chemical substance; key hazard signal: Endocrine disrupting properties (Article 57(f) - environment). Key regulatory status: SVHC Candidate List, 2 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, AICIS, SCCS, ECHA SVHC.
3-Benzylidenebornan-2-one is prohibited in EU cosmetics but has active industrial GHS classifications (H361).
CAS, identifiers, formula, and alternate names for the matched substance record.
Candidate List status and reason under the ECHA REACH SVHC program.
| Substance | Reason | Included |
|---|---|---|
| 1,7,7-trimethyl-3-(phenylmethylene)bicyclo[2.2.1]heptan-2-one | Endocrine disrupting properties (Article 57(f) - environment) | 15-Jan-2019 |
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| IFRA Transparency | IFRA | IFRA |
| banned; Europe; Personal care | European Commission | CosIng |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| =0.21 | mg/kg bw | - | oral | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| =2 | % | - | - | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 2 | % | - | oral | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| =7.5 | mg/kg bw/d | - | oral | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 15 | mg/kg bw/day | - | oral | mouse | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 15 | mg/kg bw/day | - | oral | mouse | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| =15 | mg/kg bw/d | - | oral | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 18 | - | - | dermal | human | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 18 | - | - | dermal | human | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 25 | mg/kg bw/d | - | oral | guinea pig | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 50 | mg/kg bw/day | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 50 | % | - | oral | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 2F60H204CM | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 2F60H204CM | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 2F60H204CM | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 2F60H204CM | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| =0.21 | mg/kg bw | NOAEL | oral | rat | SCCS_vision_codex |
| =0.21 | mg/kg bw | NOAEL | oral | rat | SCCS_vision_codex |
| =0.21 | mg/kg bw | NOAEL | oral | rat | SCCS_vision_codex |
| =0.21 | mg/kg bw | NOAEL | oral | rat | SCCS_vision_codex |
| =2 | % | NOAEL | - | rat | SCCS_vision_codex |
| =2 | % | NOAEL | - | rat | SCCS_vision_codex |
| =2 | % | NOAEL | - | rat | SCCS_vision_codex |
| =2 | % | NOAEL | - | rat | SCCS_vision_codex |
| =7.5 | mg/kg bw/d | NOAEL | oral | rat | SCCS_vision_codex |
| =7.5 | mg/kg bw/d | NOAEL | oral | rat | SCCS_vision_codex |
| =7.5 | mg/kg bw/d | NOAEL | oral | rat | SCCS_vision_codex |
| =7.5 | mg/kg bw/d | NOAEL | oral | rat | SCCS_vision_codex |
| =15 | mg/kg bw/day | NOAEL | oral | mouse | SCCS_vision_codex |
| =15 | mg/kg bw/d | NOAEL | oral | rat | SCCS_vision_codex |
| =15 | mg/kg bw/day | NOAEL | oral | mouse | SCCS_vision_codex |
| =15 | mg/kg bw/d | NOAEL | oral | rat | SCCS_vision_codex |
| =15 | mg/kg bw/day | NOAEL | oral | mouse | SCCS_vision_codex |
| =15 | mg/kg bw/d | NOAEL | oral | rat | SCCS_vision_codex |
| =15 | mg/kg bw/day | NOAEL | oral | mouse | SCCS_vision_codex |
| =15 | mg/kg bw/d | NOAEL | oral | rat | SCCS_vision_codex |
| =18 | - | NOAEL | dermal | human | SCCS_vision_codex |
| =18 | - | NOAEL | dermal | human | SCCS_vision_codex |
| =18 | - | NOAEL | dermal | human | SCCS_vision_codex |
| =18 | - | NOAEL | dermal | human | SCCS_vision_codex |
| =20 | mg/kg bw/day | NOAEL | oral | rat | SCCS_vision_codex |
| =20 | mg/kg bw/day | NOAEL | oral | rat | SCCS_vision_codex |
| =20 | mg/kg bw/day | NOAEL | oral | rat | SCCS_vision_codex |
| =20 | mg/kg bw/day | NOAEL | oral | rat | SCCS_vision_codex |
| =25 | mg/kg bw/d | NOAEL | oral | guinea pig | SCCS_vision_codex |
| =25 | mg/kg bw/d | NOAEL | oral | guinea pig | SCCS_vision_codex |
| =25 | mg/kg bw/d | NOAEL | oral | guinea pig | SCCS_vision_codex |
| =25 | mg/kg bw/d | NOAEL | oral | guinea pig | SCCS_vision_codex |
| =40 | mg/kg bw/day | NOAEL | - | - | SCCS_vision_codex |
| =40 | mg/kg bw/day | NOAEL | - | - | SCCS_vision_codex |
Showing 50 of 68 studies
Australian industrial chemicals inventory status and applicable conditions.
EU Scientific Committee opinions tied to the matched substance.
| Opinion | Date | Conclusion | Max Conc. | Concerns |
|---|---|---|---|---|
| SCCS/1513/13 | 18 June 2013 | not safe (endocrine disrupting) | Not safe at any recommended level | Estrogenic endocrine disruptor; not permitted in EU cosmetics (removed from Annex VI UV filters) |
Same-CAS cosmetic ingredient record for cross-vertical context.
3-Benzylidenebornan-2-one has 68 NOAEL studies in the database. The lowest reported value is 0.21 mg/kg bw via oral in rat. Source: UnifiedCodex:SCCS_SHADOW:beta.noael_studies.
3-Benzylidenebornan-2-one appears on 2 regulatory/inventory lists including IFRA Transparency, banned; Europe; Personal care. Source: EPA CPDat.
Yes, 3-Benzylidenebornan-2-one is listed on the ECHA REACH Candidate List as a Substance of Very High Concern. Reason: Endocrine disrupting properties (Article 57(f) - environment). Source: ECHA SVHC Candidate List.
Yes, 3-Benzylidenebornan-2-one is also indexed as a cosmetic ingredient under the name 3-Benzylidene Camphor. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from EPA ToxValDB, EPA CPDat, AICIS (Australian Industrial Chemicals Introduction Scheme), EPA DSSTox, ECHA SVHC Candidate List, CosIng / Ingredients DB. All data traces to primary regulatory sources and is updated from official government databases.
3-Benzylidenebornan-2-one is prohibited in EU cosmetics but has active industrial GHS classifications (H361).
3-Benzylidenebornan-2-one also appears in cosmetics databases.